International IP Arbitration – A Blessing Or A Bad Idea?
Contract Dispute Trends In Medtech
Medtech companies traditionally resolved disputes over IP rights before national courts, but more and more of them are now turning to international arbitration to protect their IP rights. Dorothee Schramm, a partner at Sidley Austin specializing in international commercial disputes, explains the benefits of this growing trend and the pitfalls to avoid.
You may also be interested in...
Conflict Management Strategies And Dispute Resolution Clauses – Ensuring Your International Contract Will Be Enforced
Medtech companies doing business in today’s environment inevitably need to enter into international supply and distribution contracts, licensing deals and collaboration agreements. Contracts often give rise to partnership conflicts, so inserting an effective dispute resolution clause is an important risk management tool and insurance for your business deal.
Clinical trial sponsors can obtain valuable support from contract research organizations (CROs) but nonetheless remain liable for the conduct of their trials. Sidley Austin partner Dorothee Schramm and senior associate Katie von der Weid, both specialized in international commercial disputes, share tips to protect against common problems that can arise during the course of clinical trials.
The COVID-19 pandemic is disrupting global supply chains and companies need effective tools to manage the related contract disputes. Sidley Austin partner Dorothee Schramm and senior associate Katie von der Weid, both specialized in international commercial disputes, provide tips to help companies manage the situation.